Results 91 to 100 of about 551,256 (383)

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans

open access: yesEmerging Infectious Diseases, 2019
Ebola virus disease (EVD) is associated with elevated cytokine levels, and hypercytokinemia is more pronounced in fatal cases. This type of hyperinflammatory state is reminiscent of 2 rheumatologic disorders known as macrophage activation syndrome and ...
Anita K. McElroy   +13 more
doaj   +1 more source

Macrophage activation syndrome in children with Kikuchi-Fujimoto disease

open access: yesPediatric Rheumatology Online Journal, 2023
Background Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. However, some patients may have a prolonged or recurrent disease course, or present with life-threatening complications such as macrophage activation ...
Zixuan Shen   +4 more
doaj   +1 more source

Immunomodulation in sepsis-induced macrophage activation syndrome in children

open access: yesIndian Pediatrics Case Reports, 2023
Background: Sepsis is a state of systemic inflammation due to an infectious etiology that may lead to multisystem dysfunction, hemodynamic instability, and even death.
Ashna Kumar   +4 more
doaj   +1 more source

Network Topologies and Dynamics Leading to Endotoxin Tolerance and Priming in Innate Immune Cells [PDF]

open access: yesPLoS Comput Biol 8(5): e1002526, 2012, 2012
The innate immune system, acting as the first line of host defense, senses and adapts to foreign challenges through complex intracellular and intercellular signaling networks. Endotoxin tolerance and priming elicited by macrophages are classic examples of the complex adaptation of innate immune cells.
arxiv   +1 more source

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. [PDF]

open access: yes, 2016
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in adults and children worldwide. NAFLD has become a severe health issue and it can progress towards a more severe form of the disease, the non-alcoholic ...
Feldstein, Ariel E, Povero, Davide
core   +2 more sources

CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Defining the CSF cytokine/chemokine and injury biomarker signature of glial fibrillary acidic protein (GFAP) autoimmunity can inform immunopathogenesis. CSF GFAP‐IgG‐positive samples (N = 98) were tested for 17 cytokines/chemokines, neurofilament light chain (NfL), and GFAP (ELLA, Bio‐Techne).
Yahel Segal   +11 more
wiley   +1 more source

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

open access: yesPediatric Rheumatology Online Journal, 2020
This study aimed to determine the influence of tocilizumab (TCZ) in modifying the clinical and laboratory features of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (s-JIA).
M. Shimizu   +15 more
semanticscholar   +1 more source

Systemic Lupus Erythematosus Presenting as Macrophage Activation Syndrome [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Macrophage Activation Syndrome (MAS), a potentially life threatening condition belongs to acquired cause of Hemophagocytic lymphohistiocytosis (HLH) group of diseases more often found in children than adults.
Satyabrata Guru   +3 more
doaj   +1 more source

A Tutorial of Cyber-Syndrome viewed from Cyber-Physical-Social-Thinking Space and Maslow's Hierarchy of Needs [PDF]

open access: yesarXiv, 2021
With the increase of active Internet users, various physical, social, and mental disorders have recently emerged because of the excessive use of technology. Cyber-Syndrome is known as the condition that appears due to the excessive interaction with the cyberspace, and it affects the users' physical, social, and mental states.
arxiv  

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study [PDF]

open access: yes, 2019
To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months.
Berardicurti O.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy